Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma
Status:
Completed
Trial end date:
2019-06-14
Target enrollment:
Participant gender:
Summary
The purpose of the trial was to evaluate the efficacy and safety of two different doses of
QVM149 (QVM149 150/50/80 μg and QVM149 150/50/160 μg via Concept1) over two respective QMF149
doses (QMF149 150/160 μg and QMF149 150/320) μg via Concept1 in poorly controlled asthmatics
as determined by pulmonary function testing and effects on asthma control.